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Abstract 
Purpose: Even though various types of scaffolds have been used lately as a complement to microfracture, the 
exact mechanism of reported cartilage repair improvement when using scaffolds is still unclear. In this study, an 
effort has been made to identify the specific effects that scaffolds may have on the cells of reparation when using 
this technique.
Methods: A 3‑D model in vitro, representing microfracture and containing both chondrocytes and bone marrow‑
derived cells in different experimental conditions was made, and the cells were cultured for eight weeks. Subse‑
quently, the constructs containing our 3‑D model were removed from the cell culture medium, fixed in paraffin and 
analyzed with immunohistochemistry.
Results: Bone marrow – derived cells migrated to the upper compartment of the construct through a perforated 
nylon membrane containing both enzymatically digested‑ and non‑digested particulated cartilage. The histological 
sections were stained with hematoxylin, eosin, S‑100, SOX‑9, Gomori, and procollagen type I and II. When minced 
cartilage wasn’t pretreated with collagenase, exclusively bone‑derived cells have created new extracellular matrix as 
showed by the histological analysis.
Conclusions: In this model of microfracture, bone‑derived cells but not chondrocytes have shown to have an active 
role in new cartilage formation without predigestion with collagenase. Moreover, it seems that the addition of a 
chitosan‑based scaffold may lead to the improvement of a new cartilage matrix synthesis and integration. This effect 
hasn’t been seen without the use of scaffold or when a fibrin‑ or a collagen‑based scaffold have been used.
© The Author(s) 2021. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which 
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the 
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or 
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line 
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory 
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this 
licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
Introduction
Even though microfracture as a technique has been in 
use for a long time [29], a discussion about the exact 
mechanism for cartilage repair during this technique 
and cartilage repair techniques derived from it is still 
open [10]. This technique will not be more thoroughly 
described here since it is the best known and most widely 
used cartilage repair procedure at the present. What’s 
important to mention here is that it’s based on the bone 
marrow stimulation using mesenchymal stromal cells 
(MSCs) from the subchondral bone for regeneration 
[29]. A variety of matrix-assisted microfracture tech-
niques have been in use since the original technique was 
developed [9, 22]. The AMIC (Assisted Matrix Induced 
Chondrogenesis) technique is one of those scaffold-based 
techniques which was derived from the microfracture 
[21]. It has been known that these techniques may lead 
to the creation of hyaline and fibrocartilage [11] but the 
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and tissue level during the repair process itself is still 
insufficient.
The main goals of the study were to detect the basic 
processes like cell migration and differentiation, extra-
cellular matrix formation and expression of some crucial 
bio-markers of chondrogenesis depending on different 
experimental conditions – absence or presence of three 
different types of scaffolds, i.e. fibrin, collagen-based and 
chitosan-based scaffold. The method used was procol-
lagen type I, procollagen type II, and SOX-9 detection 
as one of the crucial biomarkers of fibrocartilage, hya-
line cartilage and chondrogenesis respectively [3, 30]. 
Gomori’s staining for detection of extracellular carti-
lage matrix formation has also been used [8]. The main 
study hypothesis was that the use of the scaffolds would 
improve all the parameters mentioned above.
Materials and methods
A 3-D model in  vitro that should represent the micro-
environment that is created by microfracturing (Fig.  1) 
was made and the cells were cultured for eight weeks 
in different experimental conditions. Subsequently, the 
Fig. 1 Microfracture 3D – model used in our experimental setup 
in vitro: EZ Derm® – porcine epidermis. Minced cartilage. Fibrin matrix 
– in some groups it has been replaced with chitosan‑based matrix. 
PET membrane with 4 µm pores and perforated with BD Microlance® 
21 g × 1"—0,8 × 25 mm needle. Bone chips at the bottom of plastic 
well
Table 1 Eight weeks of culture in CellCrown®. Perforated PET membrane in all groups. Some groups weren’t pretreated 
with collagenase while the others were predigested with both low and high enzyme concentrations. Some groups didn’t 
contain any scaffold, some groups contained fibrin, some groups EZ-derm®, while  other groups contained chitosan-
based scaffold. Upper compartment with  PET membrane was  fixated, emerged in  paraffin and  histology sections 
were made. Hematoxylin, eosin and  trichrome staining was  done. Immunohistochemistry analysis for  four markers 
was performed: procollagen type I and II, SOX-9 and S-100
Well Plate Bone Cartilage Collagenase (conc.) Fibrin EZ-derm Chitosan
1 A  +  + ‑ ‑ ‑  + 
2 A  +  + ‑ ‑  + ‑
3 A  +  + ‑ ‑  + ‑
4 A  +  + ‑  +  + ‑
5 A  +  + ‑ ‑  + ‑
6 A  +  + ‑  +  + ‑
7 A  +  + ‑ ‑  + ‑
8 B  +  + Low ‑ ‑  + 
9 B  +  + Low ‑  + ‑
10 B  +  + Low  +  + ‑
11 B  +  + Low ‑  + ‑
12 B  +  + Low  +  + ‑
13 B  +  + Low ‑  + ‑
14 B  +  + High ‑ ‑  + 
15 B  +  + High ‑  + ‑
16 B  +  + High  +  + ‑
17 B  +  + High ‑  + ‑
18 B  +  + High  +  + ‑
19 B  +  + High ‑  + ‑
20 B ‑  + High ‑  + ‑
21 A  + ‑ ‑ ‑  + ‑
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constructs containing a 3-D model were removed from 
the cell culture medium, fixed in paraffin and analyzed 
with immunohistochemistry.
Culture of cartilage in a 3-D model
Cartilage and trabecular bone were obtained from the 
discarded femoral heads during hip arthroplasty (two 
patients, both women, Pat. No. 1, 70 years of age, Pat. No 
2, 69 years of age, both with osteoarthritis grade II-IV), as 
well as from the patients undergoing total knee replace-
ment surgery, where macroscopically normal cartilage 
could be found in the lateral femoral condyle area (two 
patients, both women, Pat. No. 3, 76 years of age, Pat. No 
4, 75 years of age). The specimens from all four patients 
were collected and the experiments were repeated for 
each of them. The cartilage was cut into small pieces 
(1–2  mm3) and the trabecular bone was cut into bone 
chips small enough to fit the wells and the space under 
the inserts, and then incubated in different experimental 
settings according to Table 1, some of them without and 
some of them with 20 units/ml collagenase II, respectively 
100 units/ml collagenase II (Sigma-Aldrich, Missouri, 
USA) in Dulbecco’s modified eagle medium (DMEM) 
nutrient solution (ThermoFisher, Waltham, Massachu-
setts, USA) at 37 °C for 16 h under gentle movement. The 
samples were centrifuged at 260xg for five minutes and 
washed in 10 ml phosphate buffered saline (PBS) (Ther-
moFisher, Waltham, Massachusetts, USA) followed by 
centrifuged for 260xg for five minutes. The final pellet 
was then placed in a special insert containing 8-μm PET 
or 1.2-μm nylon membrane (Fig. 1; CellCrown™24, Cat. 
Nr. C70001F, C12001F, Scaffdex, Tampere, Finland) per-
forated with a sterile 0.6 × 25-mm needle. In this model, 
this upper compartment should represent the cartilage 
defect that could be found in microfracture after debride-
ment of cartilage injury. The needle perforations through 
the membranes in the bottom of the inserts represented 
the holes that are made in the subchondral bone during 
microfracture. The fibrin matrix, replacing natural fibrin 
that could be found in the “super clot” [29] post micro-
fracture (TISSEEL DUO QUICK, Baxter, Sweden) was 
then added covering in total cartilage fragments, and the 
inserts were placed onto the top of the cancellous bone 
biopsies previously situated in a sterile 24-well plate. In 
this model, the cancellous bone chips represented the 
subchondral bone in microfracture and could easily be 
separated from the inserts at the end of cell culturing 
and prior to inserts analysis. Finally, some inserts were 
left without any scaffolds, in some of them as previously 
mentioned, fibrin was added, while some inserts were 
filled with chitosan-based scaffold made by this research 
group and some were covered with EZ Derm® – porcine 
skin consisting of a superficial thin layer mainly made of 
dead cells – epidermis, and another much thicker layer 
– dermis consisting mainly of collagen fibers, which 
should replace commercially available collagen-based 
scaffolds currently used in certain cartilage repair tech-
niques. Wells were filled with DMEM supplemented with 
20% fetal bovine serum (FBS) and antibiotics, so called 
“growth medium” that has been changed after a week 
with a DMEM supplemented with 10% serum. The nutri-
ent solution was changed twice a week for eight weeks 
with DMEM and 10% FBS. An overview of the contents 
of the wells is shown in Table 1.
Fixation and dehydration of cultures
After 8  weeks of culture, the content of the inserts 
was taken out and positioned in padded cassettes so 
that central portions were facing surface after paraf-
fin embedding. Specimens were fixed in 3.7% formalde-
hyde. Dehydration was performed with Tissue Processor 
TPC15DUO (Medite GmbH, Burgdorf, Germany).
Embedding and sectioning
After dehydration, fixed specimens were embedded in 
paraffin. Four micrometer tissue sections were generated 
with Leica RM2255 automatic microtome (Leica biosys-
tems, Mölndal, Sweden). The sections were floated in a 
cold-water bath and mounted on Super frost® plus gold 
microscope glass-slides (Fisher Scientific, Gothenburg, 
Sweden). Slides were placed on a hot plate for one min-
ute. Slides were placed in a 60 °C heating cabinet for four 
days.
Hematoxylin and eosin staining
The sections were rehydrated in xylene/ ethanol/water, 
stained with Mayer’s hematoxylin (Histolab, Gothenburg, 
Sweden) for five minutes and rinsed with tap water for 
four minutes. After that, they were stained for one min-
ute in eosin solution (distilled water, 0.25% eosin, 80% 
ethanol, and 90  mM acetic acid) and rinsed with tap 
water for one minute. Finally, the sections were dehy-
drated in distilled water/ethanol/xylene and mounted 
with cover slips and Pertex mounting agent (Histolab, 
Gothenburg, Sweden).
Gomori’s trichrome staining
Rehydrated sections were stained with Harris hematoxy-
lin for six minutes and rinsed for five minutes with tap 
water. Sections were stained with Gomori’s stain solu-
tion A (0.6% chromotrope 2R, 0.6% phosphovolvic acid 
hydrate, 0.3% Fast Green FCF, 0.17  M acetic acid and 
distilled water) for ten minutes and rinsed with distilled 
water. Slides were briefly immersed in Gomori’s stain 
solution B (0.35 M acetic acid and distillate water), dehy-
drated and mounted.
Page 4 of 9Andjelkov et al. J EXP ORTOP            (2021) 8:12 
Immunohistochemistry
Immunohistochemistry staining was performed with 
Dako REAL ™ EnVision ™ Detection System Peroxidase / 
DAB + , Rabbit / Mouse (Dako, Agilent, Santa Clara, Cal-
ifornia, USA). Rehydrated sections were washed twice in 
wash buffer and incubated with Proteinase K for ten min-
utes. Thereafter, they were rinsed twice with wash buffer 
and incubated with primary antibodies S100 (Ther-
moFisher, Waltham, Massachusetts, USA), procollagen 
II (Abcam, Cambridge, UK) or Sox9 (Abcam, Cambridge, 
UK), diluted 1: 500 for 30 min. The sections were rinsed 
then with wash buffer twice and incubated with peroxi-
dase blocking for eight minutes. Next, the sections were 
rinsed with wash buffer twice and incubated with EnVi-
sion complex for 30 min. Sections were rinsed twice with 
washed buffer and incubated with Chromium (DAB) for 
15 min. Sections were rinsed with wash buffer twice and 
rinsed in running tap water for 5 min. Finally, they were 
stained with Mayer’s hematoxylin for ten seconds and 
rinsed with tap water for five minutes. After dehydration, 
slides were mounted with Pertex mounting agent.
Results
Culture of cartilage in a 3-D model
Bone marrow—derived cells migrated to the upper com-
partment of the construct through a perforated nylon 
membrane containing either enzymatically digested- or 
non-digested particulated cartilage. If not predigested 
with collagenase,  the chondrocytes weren’t able to escape 
the matrix and remained within the cartilage pieces.
Hematoxylin and eosin staining
Bone-marrow derived cells have migrated towards 
minced cartilage (Fig.  2), New, extracellular matrix was 
created outside the non-digested cartilage pieces (Fig. 2). 
Without cellular elements in the upper compartment, 
i.e. chondrocytes, but only EZ-derm, no bone-marrow 
Fig. 2 Minced cartilage + bone chips + fibrin, no digestion with 
collagenase (Well 4): Positive staining with S‑100 for chondrocytes 
situated in the lacunas, no chondrocytes seen outside the cartilage 
pieces (marked with black arrow). Cell elements with extracellular 
matrix beneath the cartilage piece positioned centrally in the figure. 
These cells weren`t stained with S‑100 and supposedly originate from 
the bone chips, i.e. bone‑marrow derived cells (marked with white 
arrow). In the upper corner porcine epidermis with no cell elements 
(marked with red arrow) can be seen. No adhesion of the newly 
formed matrix with the piece of cartilage
Fig. 3 New cartilage formation in the upper part of the photo 
detected with Gomori staining and visualized in blue (marked with 
black arrow, well 8). The cell elements situated within the newly 
formed cartilage matrix. Chitosan based scaffold served as a matrix in 
the lower compartment stained in pink (marked with white arrow). 
God adhesion of the newly formed extracellular matrix to the scaffold
Fig. 4 Some week positive signals for SOX‑9 stained cells in the 
newly formed cartilage matrix from the digested particulated 
cartilage (marked with black arrow, well 10). Minced cartilage in 
the middle (marked with white arrow). Poor adhesion of the newly 
formed matrix with the piece of cartilage
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derived cells migration were noticed towards or through 
the membrane.
Gomori’s trichrome staining
A collagen-specific extracellular matrix next to the chi-
tosan-based scaffold was confirmed with trichrome 
(Gomori) staining (Fig. 3). The attempts to show positive 
staining with trichrome failed in all other experimen-
tal groups with the exception of non-digested cartilage 
pieces, which were stained as expected.
Immunohistochemistry
Chondrocytes were identified by staining with S-100 
and bone derived cells were remained unstained (Fig. 2). 
Bone-derived cells and not chondrocytes have created 
new extracellular matrix in the groups without cartilage 
digestion as showed by S-100 staining (Fig. 2). When pre-
digested with collagenase, chondrocytes from minced 
cartilage have formed new cartilage matrix as well 
(Fig.  4). SOX-9 staining was proved to be positive both 
inside the cartilage pieces (Fig. 5) and with less intensity 
in the newly created cartilage matrix (Fig. 4). In the last 
case, chondrocytes within the non-digested cartilage 
pieces remained unstained with SOX-9 (Fig. 4). Staining 
with procollagen type II was positive inside of minced 
cartilage (Fig. 6d), but not outside of it (Fig. 5c). The anti-
body for procollagen type I gave a strong non-specific 
staining, the reason why it couldn’t be used for further 
analysis (Fig. 5a and b).
Discussion
The main findings of this study are the observations 
related to the use of different type of scaffolds on basic 
processes like cell migration, differentiation and creation 
of new cartilage matrix. We have seen in this study the 
differences in these important processes depending on 
the absence of any scaffold or the use of various type of 
scaffolds, namely fibrin, collagen-based or/and chitosan-
based scaffold. At present, there are numerous reports of 
the improvement of cartilage repair with the use of vari-
ous types of scaffolds [2, 22], while other reports show 
no such effect [12, 16]. Most of those studies have been 
conducted as clinical trials [16, 22], giving us the objec-
tive measures such as histology and clinical scores, which 
Fig. 5 Cartilage cultivation containing cartilage pieces treated with 100 U/ml collagenase and cultured with fibrin matrix (Well 16). a and 
b: Fibrin respectively cartilage. Figure a representing immunohistochemistry with antibody against procollagen type I that was non‑specific 
and b representing positive staining within cartilage. c and d: Fibrin respectively cartilage. Negative respectively positive immunohistochemistry 
with antibody against procollagen type II. e and f: Fibrin respectively cartilage. Negative respectively positive immunochemistry with antibody 
against sex‑determining region Y‑related high‑mobility‑group box 9 (SOX‑9). g: Negative control for SOX‑9
Fig. 6 Immunohistochemistry with S‑100 (Well 8). Scaffold in the 
lower corner (marked with white arrow), newly formed cartilage 
matrix in the upper corner (marked with black arrow). Sporadic 
staining with S‑100 at the periphery of the newly formed cartilage 
matrix and more abundant signals in the newly formed cartilage next 
to the scaffold (marked with black arrow). God adhesion of the newly 
formed extracellular matrix to the scaffold
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naturally is of greatest interest. Numerous animal stud-
ies have been conducted as well, prior to the use of these 
scaffolds in humans [12, 32], providing us with the his-
tology of the repaired tissue when using different scaf-
folds or without them [12, 32]. However, the studies on 
the basic level, preceding both animal models and clini-
cal trials are not abundant and the authors of this article 
have failed to find them in the literature. Therefore, this 
3-D model in vitro of microfracture, presented here can 
be seen as an attempt to add some new knowledge to this 
topic and would hopefully lead to the improvement of 
the scaffolds used in matrix-assisted microfracture tech-
niques prior to their clinical use and subsequently the 
improvement of clinical outcomes as well.
Scaffold-free experimental setup
The most relevant observation when not having any scaf-
fold in the upper compartment has been that cellular 
migration towards and within upper compartment hasn’t 
been noticed. This finding is somehow expected since it 
has been known that the fibroblast-like cells that are phe-
notypically similar to MSCs [7] when in culture may need 
chemo-tactical, mechano-tactical and electro-tactical 
factors for cell migration [6, 25]. This would be one of the 
main limitations of this model since it has been known 
that even without the scaffold, the space within debrided 
cartilage is almost immediately filled with blood, growth 
factors and fibrin, a so called “super clot” formation [29].
Another limitation of this model that should be men-
tioned and discussed at this point is the use of colla-
genase in certain experimental groups. In this 3-D model 
of microfracture in  vitro bone-derived cells and not 
chondrocytes have shown to have an active role in new 
cartilage formation when minced cartilage haven’t been 
pretreated with collagenase. However, when digested 
with collagenase, chondrocytes alone from particulated 
cartilage have created a neocartilage formation. Under 
normal circumstances, the predigestion with collagenase 
during microfracture procedure doesn’t occur. Since it 
has been known from a previous study from this group 
[1] that the chondrocytes wouldn’t be able to escape the 
matrix without the enzymatic digestion, the collagenase 
has been used. This finding has been confirmed even in 
this study since no outgrowth of chondrocytes has been 
noticed in the non-digested experimental groups (Fig. 2). 
However, even in a normal, clinical situation in microf-
rature, a smaller amount of proteolytic enzymes may be 
present at the site of injury and inflammation [17, 28]. 
Nonetheless, this concentration is unlikely to be in such 
high concentrations as those used in the experiments and 
therefore it doesn’t seem likely that chondrocyte relase 
occurs in microfracture. Consequently, the probability 
that in a clinical situation during microfracture the enzy-
matic digestion of cartilage takes place so that “released” 
chondrocytes can participate actively in the novel carti-
lage matrix synthesis is very low. Finally, no significant 
differences have been found for 20 units/ml collagenase 
II, respectively 100 units/ml collagenase II.
Fibrin scaffold
Fibrin has been used widely in cartilage repair proce-
dures both alone as a scaffold [31] or as a glue to secure 
the scaffold in place post surgery [24]. In the experimen-
tal model applied in this study, it hasn’t been seen any 
migration of the cells into the fibrin matrix and there-
fore no new extracellular matrix formation inside. Simi-
larly, very poor or no integration to other scaffolds and 
extracellular matrices has been noticed (Figs.  2 and 4). 
A commercially available fibrin preparation has been 
used in this study, very similar to those routinely used 
for matrix fixation during matrix-assisted microfracture 
techniques [27]. Despite the mechanical equivalency, this 
fibrin preparation differs in some characteristics from the 
autologous one that may be present in the normal clinical 
situation in microfracture [14].
Collagen-based scaffold
As for the collagen-based matrices, the explanation has 
already been given in the “Materials and Methods” sec-
tion for the choice of use of EZ-derm® as a substitute for a 
collagen-based matrix. Indeed, this type of scaffolds has 
been widely used in so-called matrix-assisted microfracture 
techniques [16]. By its structure, the EZ-derm® is almost 
identical to the one of most commonly used matrices in 
cartilage repair which has also been derived from the por-
cine skin – Chondro- Gide® [27]. In the histological sections 
obtained in this study, scarce or no cell migration has been 
seen towards or into the EZ-derm® (Figs. 1 and 2). Subse-
quently, no extracellular matrix production has been iden-
tified next to it (Fig. 2). The poor integration of EZ-derm® 
with the other components of the construct has been seen 
as well (Fig. 2). In this experimental group, the new carti-
lage matrix has been synthesized separately and beneath 
the EZ-derm® (Fig. 2). As previously mentioned, chondro-
cytes within minced cartilage have been stained with S-100 
(Fig. 2) as a rule. The staining with procollagen type II has 
been positive within minced cartilage and so far, hasn’t been 
detected outside of it, in the newly formed extracellular 
matrix to be more specific (Fig. 5c and d). At the present, the 
conclusion that can be made from these findings is that the 
chondrocytes from minced cartilage are metabolically active 
and are still producing new collagen type II after 8  weeks 
in culture [4, 13]. As said previously, the staining with pro-
collagen type I was unspecific and therefore these results 
can´t be used for any further analysis (Fig. 5a and b). Future 
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immunohistochemistry for both procollagen type I and II is 
recommended for better understanding of their expression 
dynamics and distribution in newly created extracellular 
matrix. This with concern to the fact that collagen type I is 
primarily expressed in fibrocartilage [19] while collagen type 
II is the crucial marker of hyaline-like cartilage [33]. That is 
why it is very important to further examine the expression 
of these two biomarkers, specifically in relation to their pres-
ence in scaffolds or not. The staining with SOX-9 has mainly 
been detected in cartilage pieces (Fig. 5f). At the same time, 
weak SOX-9 staining has been noticed in the newly formed 
cartilage matrix (Fig.  4). This matrix has been synthetized 
from the chondrocytes originated from digested particu-
lated cartilage. According to the previous reports the SOX-9 
gene is expressed from the multipotent skeletal progenitor 
stage and is active throughout chondrocyte differentiation 
[18]. It is repressed in hypertrophic chondrocytes in carti-
lage growth plates but remains expressed throughout life 
in permanent chondrocytes of healthy articular cartilage 
[18]. The absence of SOX-9 expression in matrix in most 
of the cases therefore suggests the presence of cells other 
than chondrocytes in these sections, most probably bone-
marrow derived cells. Reportedly, MSCs become hyper-
trophic in long term despite chondrogenic differentiation 
following the pathway of growth plate chondrocytes [26]. 
All together, by failing to prove both the markers of chon-
drogenesis (SOX-9, procollagen type I and II), the marker of 
adult chondrocyte phenotype (S-100) in the cell elements 
within the newly synthetized extracellular matrix, and carti-
lage-like nature of that matrix (trichrome/Gomori staining), 
the chondrogenic potential of the collagen-based scaffold in 
this experimental model hasn’t been confirmed. In addition 
to that, as previously said very poor integration with other 
components of the insert, as well as scarce cell adhesion 
have been detected.
Chitosan-based scaffold
Chitosan has been routinely used as a scaffold in carti-
lage repair [22]. Some very good clinical data have been 
reported on its use [22]. In this model, similarly as in the 
case of collagen-based scaffolds, a substitute to the com-
mercially available scaffold has been used. This time, the 
scaffold used was made by this research group. At this 
point, a further description of the scaffold character-
istics is unfortunately not possible due to patent rights 
protection.
First of all, an excellent integration of the newly 
formed cartilage matrix, as proved by Gomori’s stain-
ing, has been seen (Fig.  3). These two findings speak 
strongly in favour of the chondrogenic potential of 
this scaffold. However, only certain cells in the newly 
formed cartilage matrix have been stained with S-100. 
These were mainly situated next to the chitosan-based 
scaffold (Fig.  6). From past studies it has been known 
that S-100 is expressed in differentiated MSCs but not 
in an undifferentiated cell form [5]. One explanation 
could be that chondrocytes have been detected in the 
newly created extracellular matrix. The other possible 
explanation could be that not all chondrocytes express 
S-100 as it has been reported before [20]. In this study, 
the immunostaining for both S-100 sub units (a and 
b) was detected in chondrocytes in superficial, inter-
mediate, and deep zones of normal articular cartilage 
[20]. However, in matrix, only the superficial zone was 
stained positively [20] In arthritic joints, intense immu-
nostaining was detected in clustered chondrocytes in 
the hypercellular area, while weak or no immunostain-
ing have been seen in isolated chondrocytes in the 
hypocellular area of articular cartilage [20].
No staining with SOX-9 has been detected next to the 
chitosan-based scaffold. SOX-9 is a transcription factor 
that regulates chondrogenesis and its role in chondro-
genic differentiation of MSCs triggered by materials is 
poorly understood [15]. A study has shown that the role 
of SOX-9 regulation by materials is like that of growth 
factors, suggesting that a well-designed scaffold may 
replace growth factors in chondrogenesis [15]. A correla-
tion between cell viability and SOX-9 downregulation has 
also been reported [23]. Probably, additional experiments 
should be done at different times to look for the expres-
sion of this and other bio-markers. This could be one of 
the main flows of this study.
Finally, similar to the case of other scaffolds no or very 
poor migration of the cells into the depth of the matrix 
has been seen. However, the preliminary data that hasn’t 
been reported in this study shows scarce cell migration 
into this matrix by identifying cellular DNA inside of the 
matrix. Again, not going into details about the matrix 
structure, the pore size should be enlarged to increase 
the permeability of the matrix for the cells.
This 3-D model of microfracture in vitro may be seen 
as a very useful tool for the analysis of the basic cell 
processes in microfracture and the influence of differ-
ent scaffolds on the processes leading to cartilage repair. 
Furthermore, it could serve as a suitable environment 
for making modifications and improvements in scaffolds 
prior to their clinical use in the matrix-assisted microf-
rature techniques. The authors of this text consider that 
as the main clinical relevance and contribution of this 
3-D´model. Further studies should be conducted for 
better understanding of the dynamics of cartilage bio-
markers expression in microfracture and the influence of 
different types of scaffolds and their adjustments on this 
expression and neocartilage formation.
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